Higher Frequency of Dipeptidyl Peptidase-4 Inhibitor Intake in Bullous Pemphigoid Patients than in the French General Population-Reference-Cited by-同舟云学术

Higher Frequency of Dipeptidyl Peptidase-4 Inhibitor Intake in Bullous Pemphigoid Patients than in the French General Population

Published:2019-04 Issue:4 Volume:139 Page:835-841
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Plaquevent Marthe^ORCID,Tétart Florence,Fardet Laurence,Ingen-Housz-Oro Saskia,Valeyrie-Allanore Laurence,Bernard Philippe,Hebert Vivien,Roussel Aude,Avenel-Audran Martine,Chaby Guillaume,D’Incan Michel,Ferrier-Le-Bouedec Marie-Christine,Duvert-Lehembre Sophie,Picard-Dahan Catherine,Jeudy Geraldine,Collet Evelyne,Labeille Bruno,Morice Cécile,Richard Marie-Aleth,Bourgault-Villada Isabelle,Litrowski Noémie,Bara Corina,Mahe Emmanuel,Prost-Squarcioni Catherine,Alexandre Marina,Quereux Gaelle,Bernier Claire,Soria Angèle,Thomas-Beaulieu Domitille,Pauwels Christine,Dereure Olivier,Benichou Jacques,Joly Pascal

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference60 articles.

1. Alogliptin: a new addition to the class of DPP-4 inhibitors;Andukuri;Diabetes Metab Syndr Obes Targets Ther,2009

2. A case report of bullous pemphigoid induced by dipeptidyl peptidase-4 inhibitors;Aouidad;JAMA Dermatol,2013

3. Bullous pemphigoid associated with dipeptidyl peptidase IV inhibitors. A case report and review of literature;Attaway;J Dermatol Case Rep,2014

4. Safety and tolerability of vildagliptin vs. thiazolidinedione as add-on to metformin in type 2 diabetic patients with and without mild renal impairment: a retrospective analysis of the GALIANT study;Banerji;Diabetes Res Clin Pract,2010

5. Drugs associated with bullous pemphigoid. A case-control study;Bastuji-Garin;Arch Dermatol,1996

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Identification of Risk Factors for Gliptin-associated Bullous Pemphigoid among Diabetic Patients;Acta Dermato-Venereologica;2024-04-04

3. Proteomic changes related to actin cytoskeleton function in the skin of vildagliptin-treated mice;Journal of Dermatological Science;2024-03

4. Gliptin-induced bullous pemphigoid;Int. Journal of Clinical Pharmacology and Therapeutics;2024-02-01

5. Role of regulatory T cells in pathogenesis and therapeutics of pemphigus vulgaris and bullous pemphigoid;Regulatory T Cells and Autoimmune Diseases;2024